{
  "experiment_id": "944970b794b0dafc45b69b26b90efa35",
  "task_name": "broadening_of_narrow_synonyms",
  "task_hash": "a2c885aa2a82bb5b150f213062bbeb89",
  "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
  "system_instructions": "### Temperature\n\n1.0",
  "temperature": 1.0,
  "thinking": false,
  "tools": [],
  "timestamp": "2025-12-11T05:15:59.045390",
  "task_result": {
    "task_name": "broadening_of_narrow_synonyms",
    "num_samples": 10,
    "results": [
      {
        "sample_index": 0,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 microdeletion syndrome",
          "assay": "clinical whole-exome sequencing",
          "tumorType": "Plexiform neurofibroma (morphologic abnormality)"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Broadened \"Neurofibromatosis type 1 microdeletion syndrome\" to \"Neurofibromatosis type 1\" (the microdeletion is a specific subtype; the broader diagnosis category is the standard controlled term)\n\n2. **assay**: Broadened \"clinical whole-exome sequencing\" to \"whole exome sequencing\" (removed the \"clinical\" modifier to match the exact controlled terminology value)\n\n3. **tumorType**: Standardized \"Plexiform neurofibroma (morphologic abnormality)\" to \"Plexiform Neurofibroma\" (removed the parenthetical descriptor and standardized capitalization to match the exact controlled terminology value)",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 3016,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 227
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01Tr3vn9e4PmYpBbUCkXbPoM",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Broadened \"Neurofibromatosis type 1 microdeletion syndrome\" to \"Neurofibromatosis type 1\" (the microdeletion is a specific subtype; the broader diagnosis category is the standard controlled term)\n\n2. **assay**: Broadened \"clinical whole-exome sequencing\" to \"whole exome sequencing\" (removed the \"clinical\" modifier to match the exact controlled terminology value)\n\n3. **tumorType**: Standardized \"Plexiform neurofibroma (morphologic abnormality)\" to \"Plexiform Neurofibroma\" (removed the parenthetical descriptor and standardized capitalization to match the exact controlled terminology value)"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3016,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 227
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Plexiform Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3016,
          "output_tokens": 227,
          "total_tokens": 3243
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 1,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 with optic pathway glioma",
          "assay": "Illumina whole exome sequencing ",
          "tumorType": "malignant triton tumor"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Broadened \"Neurofibromatosis type 1 with optic pathway glioma\" to \"Neurofibromatosis type 1\" - the diagnosis field should capture the primary diagnosis, not specific tumor manifestations (optic pathway glioma is captured in tumorType).\n\n2. **assay**: Corrected \"Illumina whole exome sequencing\" to \"whole exome sequencing\" - removed the vendor name to use the standard controlled terminology value.\n\n3. **tumorType**: Changed \"malignant triton tumor\" to \"Malignant Peripheral Nerve Sheath Tumor\" - malignant triton tumors are a subtype of MPNST (Malignant Peripheral Nerve Sheath Tumor) and should be broadened to the standard controlled terminology.",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 3011,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 256
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01PcpP7fy6x9FuicJAnrxXS5",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Broadened \"Neurofibromatosis type 1 with optic pathway glioma\" to \"Neurofibromatosis type 1\" - the diagnosis field should capture the primary diagnosis, not specific tumor manifestations (optic pathway glioma is captured in tumorType).\n\n2. **assay**: Corrected \"Illumina whole exome sequencing\" to \"whole exome sequencing\" - removed the vendor name to use the standard controlled terminology value.\n\n3. **tumorType**: Changed \"malignant triton tumor\" to \"Malignant Peripheral Nerve Sheath Tumor\" - malignant triton tumors are a subtype of MPNST (Malignant Peripheral Nerve Sheath Tumor) and should be broadened to the standard controlled terminology."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3011,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 256
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3011,
          "output_tokens": 256,
          "total_tokens": 3267
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 2,
        "input": {
          "diagnosis": "Watson Syndrome",
          "assay": "MGI whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: \"Watson Syndrome\" \u2192 \"Noonan Syndrome\" \n   - Watson Syndrome is a phenotypic variant of Noonan Syndrome and should be broadened to the standard terminology.\n\n2. **assay**: \"MGI whole genome sequencing\" \u2192 \"whole genome sequencing\"\n   - Removed the specific vendor/platform prefix (MGI) to use the standard controlled term.\n\n3. **tumorType**: \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\"\n   - Removed the specific histological variant descriptor to match the standard controlled terminology.",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 3010,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 223
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01FYuP9ziTNGSBSTtGzdbNe8",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: \"Watson Syndrome\" \u2192 \"Noonan Syndrome\" \n   - Watson Syndrome is a phenotypic variant of Noonan Syndrome and should be broadened to the standard terminology.\n\n2. **assay**: \"MGI whole genome sequencing\" \u2192 \"whole genome sequencing\"\n   - Removed the specific vendor/platform prefix (MGI) to use the standard controlled term.\n\n3. **tumorType**: \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\"\n   - Removed the specific histological variant descriptor to match the standard controlled terminology."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3010,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 223
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3010,
          "output_tokens": 223,
          "total_tokens": 3233
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 3,
        "input": {
          "diagnosis": "neurofibromatosis, familial spinal",
          "assay": "open MRI",
          "tumorType": "unknown - no information available"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"neurofibromatosis, familial spinal\" \u2192 \"Neurofibromatosis type 1\" \n   - The narrow term describing familial spinal neurofibromatosis is broadened to the standard diagnosis term from the controlled vocabulary.\n\n2. **assay**: \"open MRI\" \u2192 \"conventional MRI\"\n   - \"Open MRI\" is a specific type of MRI equipment; broadened to the standard controlled term \"conventional MRI\" which encompasses all standard MRI imaging methods.\n\n3. **tumorType**: \"unknown - no information available\" \u2192 \"Unknown\"\n   - Standardized to the exact controlled vocabulary value \"Unknown\" (capitalized as specified in the schema).",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 2998,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 217
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_011NtnYdZWWBZFzYT4P11nmo",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"neurofibromatosis, familial spinal\" \u2192 \"Neurofibromatosis type 1\" \n   - The narrow term describing familial spinal neurofibromatosis is broadened to the standard diagnosis term from the controlled vocabulary.\n\n2. **assay**: \"open MRI\" \u2192 \"conventional MRI\"\n   - \"Open MRI\" is a specific type of MRI equipment; broadened to the standard controlled term \"conventional MRI\" which encompasses all standard MRI imaging methods.\n\n3. **tumorType**: \"unknown - no information available\" \u2192 \"Unknown\"\n   - Standardized to the exact controlled vocabulary value \"Unknown\" (capitalized as specified in the schema)."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 2998,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 217
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2998,
          "output_tokens": 217,
          "total_tokens": 3215
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 4,
        "input": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry of skin",
          "tumorType": "Cutaneous storiform neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: No change needed - \"Not Applicable\" is already a valid controlled term.\n\n2. **assay**: Broadened \"immunohistochemistry of skin\" to \"immunohistochemistry\" - the tissue type (skin) is a qualifier that narrows the term. The controlled terminology uses the broader, general assay method.\n\n3. **tumorType**: Broadened \"Cutaneous storiform neurofibroma\" to \"Cutaneous Neurofibroma\" - \"storiform\" is a histological pattern descriptor that is more specific than the controlled terminology. The schema uses the broader classification without the histological modifier.",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 2998,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 198
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_018p6DhLfswdUvv6QpYNY85f",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: No change needed - \"Not Applicable\" is already a valid controlled term.\n\n2. **assay**: Broadened \"immunohistochemistry of skin\" to \"immunohistochemistry\" - the tissue type (skin) is a qualifier that narrows the term. The controlled terminology uses the broader, general assay method.\n\n3. **tumorType**: Broadened \"Cutaneous storiform neurofibroma\" to \"Cutaneous Neurofibroma\" - \"storiform\" is a histological pattern descriptor that is more specific than the controlled terminology. The schema uses the broader classification without the histological modifier."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 2998,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 198
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2998,
          "output_tokens": 198,
          "total_tokens": 3196
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 5,
        "input": {
          "diagnosis": "chromosome 17q11.2 deletion syndrome, 1.4Mb",
          "assay": "cell viability assay using Annexin V staining",
          "tumorType": "Pedunculated Cutaneous Neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" \u2192 \"Neurofibromatosis type 1\"\n   - The narrow synonym describing the specific genetic deletion was broadened to the standard diagnosis term. NF1 is caused by deletions/mutations in the NF1 gene on chromosome 17q11.2.\n\n2. **assay**: \"cell viability assay using Annexin V staining\" \u2192 \"cell viability assay\"\n   - Removed the specific methodology detail (Annexin V staining) to use the broader, standard assay term from the controlled vocabulary.\n\n3. **tumorType**: \"Pedunculated Cutaneous Neurofibroma\" \u2192 \"Cutaneous Neurofibroma\"\n   - Removed the morphological descriptor \"Pedunculated\" to use the standard term from the controlled vocabulary. \"Pedunculated\" is a descriptive variant of cutaneous neurofibroma, not a distinct type in the schema.",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 3020,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 294
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_016hNU2hZ7rnE53yubiHYePR",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" \u2192 \"Neurofibromatosis type 1\"\n   - The narrow synonym describing the specific genetic deletion was broadened to the standard diagnosis term. NF1 is caused by deletions/mutations in the NF1 gene on chromosome 17q11.2.\n\n2. **assay**: \"cell viability assay using Annexin V staining\" \u2192 \"cell viability assay\"\n   - Removed the specific methodology detail (Annexin V staining) to use the broader, standard assay term from the controlled vocabulary.\n\n3. **tumorType**: \"Pedunculated Cutaneous Neurofibroma\" \u2192 \"Cutaneous Neurofibroma\"\n   - Removed the morphological descriptor \"Pedunculated\" to use the standard term from the controlled vocabulary. \"Pedunculated\" is a descriptive variant of cutaneous neurofibroma, not a distinct type in the schema."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3020,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 294
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "cell viability assay",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3020,
          "output_tokens": 294,
          "total_tokens": 3314
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 6,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 with scoliosis",
          "assay": "anti-tag immunocytochemistry",
          "tumorType": "sessile cutaneous neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Removed the non-diagnostic qualifier \"with scoliosis\" to match the controlled terminology value \"Neurofibromatosis type 1\"\n\n2. **assay**: Broadened \"anti-tag immunocytochemistry\" to the standard controlled term \"immunocytochemistry\" (the \"anti-tag\" specification is a technical detail that narrows the term unnecessarily)\n\n3. **tumorType**: Broadened \"sessile cutaneous neurofibroma\" to \"Cutaneous Neurofibroma\" (the \"sessile\" descriptor is an anatomical qualifier that narrows the term; the controlled terminology uses the simpler form)",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 3011,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 212
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_016weVnWB2M97nntcY4pPM3J",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Removed the non-diagnostic qualifier \"with scoliosis\" to match the controlled terminology value \"Neurofibromatosis type 1\"\n\n2. **assay**: Broadened \"anti-tag immunocytochemistry\" to the standard controlled term \"immunocytochemistry\" (the \"anti-tag\" specification is a technical detail that narrows the term unnecessarily)\n\n3. **tumorType**: Broadened \"sessile cutaneous neurofibroma\" to \"Cutaneous Neurofibroma\" (the \"sessile\" descriptor is an anatomical qualifier that narrows the term; the controlled terminology uses the simpler form)"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3011,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 212
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "immunocytochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3011,
          "output_tokens": 212,
          "total_tokens": 3223
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 7,
        "input": {
          "diagnosis": "neurofibromatosis, peripheral type",
          "assay": "wide bore MRI",
          "tumorType": "no clear diagnosis"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Not Applicable\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"neurofibromatosis, peripheral type\" \u2192 \"Neurofibromatosis type 1\"\n   - Broadened the narrow synonym to the standard controlled terminology. \"Peripheral type\" is an older classification that aligns with NF1.\n\n2. **assay**: \"wide bore MRI\" \u2192 \"conventional MRI\"\n   - Broadened the specific equipment descriptor to the standard assay term from the controlled vocabulary.\n\n3. **tumorType**: \"no clear diagnosis\" \u2192 \"Not Applicable\"\n   - Replaced the descriptive phrase with the appropriate enum value indicating no tumor type is applicable.",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 2995,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 199
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01KUtV89MqwagPnn6GjfBN2t",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Not Applicable\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"neurofibromatosis, peripheral type\" \u2192 \"Neurofibromatosis type 1\"\n   - Broadened the narrow synonym to the standard controlled terminology. \"Peripheral type\" is an older classification that aligns with NF1.\n\n2. **assay**: \"wide bore MRI\" \u2192 \"conventional MRI\"\n   - Broadened the specific equipment descriptor to the standard assay term from the controlled vocabulary.\n\n3. **tumorType**: \"no clear diagnosis\" \u2192 \"Not Applicable\"\n   - Replaced the descriptive phrase with the appropriate enum value indicating no tumor type is applicable."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 2995,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 199
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2995,
          "output_tokens": 199,
          "total_tokens": 3194
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 8,
        "input": {
          "diagnosis": "acoustic neurofibromatosis",
          "assay": "RNA-seq with ribosomal RNA depletion",
          "tumorType": "Acoustic neuroma of left vestibular nerve"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Vestibular Schwannoma\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"acoustic neurofibromatosis\" \u2192 \"Vestibular Schwannoma\" \n   - Acoustic neuroma/neurofibromatosis refers to vestibular schwannomas, which is the broader standard terminology in the controlled schema.\n\n2. **assay**: \"RNA-seq with ribosomal RNA depletion\" \u2192 \"RNA-seq\"\n   - The methodology detail (rRNA depletion) is a technical variation of the core assay type. The controlled term is the broader \"RNA-seq\".\n\n3. **tumorType**: \"Acoustic neuroma of left vestibular nerve\" \u2192 \"Schwannoma\"\n   - Acoustic neuroma is a specific type of schwannoma. \"Schwannoma\" is the broader, standard term in the controlled schema.",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 3008,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 239
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_017N2Bt2VFdiAzfWafrhcsy2",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Vestibular Schwannoma\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"acoustic neurofibromatosis\" \u2192 \"Vestibular Schwannoma\" \n   - Acoustic neuroma/neurofibromatosis refers to vestibular schwannomas, which is the broader standard terminology in the controlled schema.\n\n2. **assay**: \"RNA-seq with ribosomal RNA depletion\" \u2192 \"RNA-seq\"\n   - The methodology detail (rRNA depletion) is a technical variation of the core assay type. The controlled term is the broader \"RNA-seq\".\n\n3. **tumorType**: \"Acoustic neuroma of left vestibular nerve\" \u2192 \"Schwannoma\"\n   - Acoustic neuroma is a specific type of schwannoma. \"Schwannoma\" is the broader, standard term in the controlled schema."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3008,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 239
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "NF2-related schwannomatosis",
          "assay": "RNA-seq",
          "tumorType": "schwannoma"
        },
        "token_usage": {
          "input_tokens": 3008,
          "output_tokens": 239,
          "total_tokens": 3247
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 9,
        "input": {
          "diagnosis": "neurofibromatosis type 1 due to NF1 mutation or intragenic deletion",
          "assay": "CellTiter-Glo\u00ae 3D Cell Viability Assay",
          "tumorType": "Epithelioid Malignant Peripheral Nerve Sheath Tumor"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Broadened \"neurofibromatosis type 1 due to NF1 mutation or intragenic deletion\" to the standard controlled term \"Neurofibromatosis type 1\" (removed the specific molecular mechanism details to use the exact enum value).\n\n2. **assay**: Broadened the specific commercial product name \"CellTiter-Glo\u00ae 3D Cell Viability Assay\" to the standard controlled term \"cell viability assay\".\n\n3. **tumorType**: Broadened \"Epithelioid Malignant Peripheral Nerve Sheath Tumor\" to \"Malignant Peripheral Nerve Sheath Tumor\" (removed the histological subtype qualifier to match the exact enum value).",
          "model_id": "us.anthropic.claude-haiku-4-5-20251001-v1:0",
          "usage": {
            "input_tokens": 3041,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 242
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-haiku-4-5-20251001",
            "id": "msg_bdrk_01U6vAxCtDThywAQjXFURpX1",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Broadened \"neurofibromatosis type 1 due to NF1 mutation or intragenic deletion\" to the standard controlled term \"Neurofibromatosis type 1\" (removed the specific molecular mechanism details to use the exact enum value).\n\n2. **assay**: Broadened the specific commercial product name \"CellTiter-Glo\u00ae 3D Cell Viability Assay\" to the standard controlled term \"cell viability assay\".\n\n3. **tumorType**: Broadened \"Epithelioid Malignant Peripheral Nerve Sheath Tumor\" to \"Malignant Peripheral Nerve Sheath Tumor\" (removed the histological subtype qualifier to match the exact enum value)."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3041,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 242
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "3D microtissue viability",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3041,
          "output_tokens": 242,
          "total_tokens": 3283
        },
        "tool_calls": [],
        "tool_execution_history": []
      }
    ],
    "metrics": {
      "total_samples": 10,
      "successful_runs": 10,
      "failed_runs": 0,
      "success_rate": 1.0,
      "average_score": 0.8333333333333333,
      "min_score": 0.3333333333333333,
      "max_score": 1.0,
      "num_scored": 10
    },
    "duration_seconds": 32.34683108329773,
    "token_usage": {
      "input_tokens": 30108,
      "output_tokens": 2307,
      "total_tokens": 32415
    }
  }
}